CH601250A5 - - Google Patents

Info

Publication number
CH601250A5
CH601250A5 CH1111874A CH1111874A CH601250A5 CH 601250 A5 CH601250 A5 CH 601250A5 CH 1111874 A CH1111874 A CH 1111874A CH 1111874 A CH1111874 A CH 1111874A CH 601250 A5 CH601250 A5 CH 601250A5
Authority
CH
Switzerland
Application number
CH1111874A
Inventor
Georg Dr Rainer
Richard Dr Riedel
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CH601250A5 publication Critical patent/CH601250A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1111874A 1973-08-16 1974-08-14 CH601250A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU68238A LU68238A1 (de) 1973-08-16 1973-08-16

Publications (1)

Publication Number Publication Date
CH601250A5 true CH601250A5 (de) 1978-06-30

Family

ID=19727442

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1111874A CH601250A5 (de) 1973-08-16 1974-08-14

Country Status (18)

Country Link
JP (1) JPS5230515B2 (de)
AT (1) AT339892B (de)
BE (1) BE818912A (de)
CA (1) CA1048499A (de)
CH (1) CH601250A5 (de)
DE (2) DE2462459C3 (de)
DK (1) DK136953B (de)
ES (1) ES429247A1 (de)
FI (1) FI57584C (de)
FR (1) FR2240732B1 (de)
GB (1) GB1475806A (de)
IE (1) IE39999B1 (de)
LU (1) LU68238A1 (de)
NL (1) NL169070C (de)
NO (1) NO140733C (de)
SE (1) SE409454B (de)
YU (1) YU222474A (de)
ZA (1) ZA745252B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5297383A (en) * 1976-02-13 1977-08-16 Ngk Spark Plug Co Ceramic honeycomb structures for exhaust gas purification
HUP0304101A3 (en) * 2003-12-22 2008-10-28 Sanofi Aventis Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates

Also Published As

Publication number Publication date
NO140733B (no) 1979-07-23
NO140733C (no) 1979-10-31
JPS5049278A (de) 1975-05-01
FR2240732B1 (de) 1978-07-21
CA1048499A (en) 1979-02-13
LU68238A1 (de) 1975-05-21
FI57584C (fi) 1980-09-10
DK136953C (de) 1978-05-29
YU222474A (en) 1983-04-27
ES429247A1 (es) 1976-08-16
BE818912A (fr) 1975-02-17
DK136953B (da) 1977-12-19
DE2438779C3 (de) 1979-09-20
IE39999B1 (en) 1979-02-14
NL7410921A (nl) 1975-02-18
DK438174A (de) 1975-04-28
GB1475806A (en) 1977-06-10
NL169070C (nl) 1982-06-01
FI57584B (fi) 1980-05-30
ZA745252B (en) 1976-03-31
DE2462459C3 (de) 1979-10-04
DE2462459B2 (de) 1979-02-08
DE2438779B2 (de) 1979-01-25
NL169070B (nl) 1982-01-04
FI242274A7 (de) 1975-02-17
AT339892B (de) 1977-11-10
SE7410419L (de) 1975-02-17
IE39999L (en) 1975-02-16
JPS5230515B2 (de) 1977-08-09
SE409454B (sv) 1979-08-20
NO742941L (de) 1975-03-17
ATA671174A (de) 1977-03-15
FR2240732A1 (de) 1975-03-14
DE2438779A1 (de) 1975-02-27
DE2462459A1 (de) 1977-04-07

Similar Documents

Publication Publication Date Title
AR201758A1 (de)
AU476761B2 (de)
AR201235Q (de)
AR201231Q (de)
AU474593B2 (de)
AU465453B2 (de)
AU471343B2 (de)
AU450229B2 (de)
AU476714B2 (de)
AR201229Q (de)
AU476696B2 (de)
AU472848B2 (de)
AR199451A1 (de)
AU466283B2 (de)
AU476873B1 (de)
FR2240732B1 (de)
AR200256A1 (de)
AR193950A1 (de)
AR195948A1 (de)
AR196382A1 (de)
AR200885A1 (de)
AR195311A1 (de)
AU477824B2 (de)
AR210729A1 (de)
AU1891376A (de)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased